Oxbow Advisors LLC Buys 511 Shares of Cigna Group $CI

Oxbow Advisors LLC raised its stake in Cigna Group (NYSE:CI) by 2.6% in the second quarter, Holdings Channel reports. The firm owned 20,153 shares of the health services provider’s stock after acquiring an additional 511 shares during the quarter. Oxbow Advisors LLC’s holdings in Cigna Group were worth $6,662,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Brighton Jones LLC increased its holdings in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after buying an additional 318 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Cigna Group by 79.0% in the 1st quarter. GAMMA Investing LLC now owns 5,394 shares of the health services provider’s stock valued at $1,775,000 after purchasing an additional 2,381 shares during the period. Exchange Traded Concepts LLC lifted its stake in Cigna Group by 7.2% in the 1st quarter. Exchange Traded Concepts LLC now owns 3,417 shares of the health services provider’s stock valued at $1,124,000 after purchasing an additional 229 shares during the last quarter. CWA Asset Management Group LLC grew its holdings in Cigna Group by 17.8% during the first quarter. CWA Asset Management Group LLC now owns 932 shares of the health services provider’s stock worth $306,000 after purchasing an additional 141 shares during the period. Finally, Boston Trust Walden Corp acquired a new position in Cigna Group during the first quarter worth approximately $233,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 1.2%

Shares of CI opened at $290.97 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. Cigna Group has a 12 month low of $256.89 and a 12 month high of $358.72. The firm’s 50 day moving average is $296.78 and its 200-day moving average is $308.51. The stock has a market capitalization of $77.67 billion, a PE ratio of 15.88, a P/E/G ratio of 0.86 and a beta of 0.45.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same quarter in the prior year, the business posted $6.72 earnings per share. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts forecast that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s payout ratio is 32.97%.

Insider Activity

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the completion of the transaction, the insider directly owned 51,182 shares in the company, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the subject of a number of recent analyst reports. Robert W. Baird set a $372.00 price objective on Cigna Group in a research report on Thursday, August 14th. Guggenheim reaffirmed a “buy” rating and set a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Weiss Ratings restated a “hold (c+)” rating on shares of Cigna Group in a research note on Wednesday, October 8th. Finally, Wells Fargo & Company upped their price target on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $369.89.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.